Saturday 17 October 2026
Export STAA’s income statement to Excel — free account
STAAR Surgical Company
STAA Healthcare Medical Instruments & Supplies
In the quarter to June 2026, revenue grew 111.0%, EPS grew 147.1% and free cash flow grew 166.1%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
21.27
0.99
−4.45%
Follow STAA
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 306.53 | 113.45 | 677.09 | 155.54 | 64.06 | 66.07 | 0.00 | 0.00 |
Piotroski F-Score |
4 | 7 | 7 | 6 | 5 | 7 | 6 | 3 | 3 | 2 |
P/S ratio |
5.23 | 7.20 | 10.96 | 10.42 | 22.10 | 18.70 | 8.65 | 4.47 | 3.80 | 4.78 |
Altman Z-Score |
7.26 | 13.71 | 23.81 | 20.47 | 36.81 | 30.96 | 18.44 | 10.30 | 7.43 | 6.44 |
Altman Z″-Score (non-manufacturers) |
(4.93) | (2.93) | 6.06 | 6.11 | 6.36 | 6.93 | 8.51 | 8.05 | 6.95 | 4.46 |
P/FCF ratio |
0.00 | 360.80 | 129.15 | 100.20 | 289.86 | 142.56 | 140.34 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
3,371.25 | 586.30 | 579.51 | 159.79 | 184.80 | 507.21 | 828.06 | 45.12 | 1,858.64 | (292.42) |
Beneish M-Score |
(3.46) | (2.70) | (2.38) | (1.78) | (2.59) | (2.14) | (1.91) | (2.02) | (3.06) | (3.29) |
P/B ratio |
11.38 | 15.18 | 10.26 | 9.79 | 18.32 | 16.67 | 7.32 | 3.74 | 3.00 | 3.33 |
Price to Tangible BV |
12.11 | 15.95 | 10.42 | 9.92 | 18.51 | 16.80 | 7.36 | 3.76 | 3.02 | 3.34 |
EV/Sales |
5.08 | 7.00 | 10.13 | 9.62 | 21.17 | 17.84 | 7.90 | 3.79 | 3.07 | 4.13 |
EV/EBITDA |
0.00 | 0.00 | 138.60 | 92.93 | 350.81 | 111.16 | 47.71 | 39.78 | 0.00 | 0.00 |
EV/Operating CF |
399.29 | 222.21 | 98.34 | 56.03 | 165.17 | 93.51 | 62.94 | 83.73 | 61.23 | (28.91) |
EV/FCF |
(194.28) | 350.84 | 119.32 | 92.54 | 277.63 | 135.97 | 128.28 | (332.31) | (124.20) | (24.65) |
Quick Ratio |
1.44 | 1.91 | 4.68 | 4.38 | 4.55 | 4.98 | 5.30 | 4.85 | 4.39 | 3.47 |
Current Ratio |
2.35 | 2.82 | 5.47 | 5.07 | 5.25 | 5.56 | 6.03 | 5.62 | 5.23 | 4.55 |
Net Debt/EBITDA |
1.30 | 64.94 | (11.42) | (7.69) | (15.45) | (5.39) | (4.49) | (7.18) | 33.84 | 2.25 |
Debt/Assets |
2.04% | 0.78% | 0.27% | 0.18% | 0.01% | 0.11% | 0.05% | 0.01% | 0.00% | 0.00% |
Debt/Equity |
0.04 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
1.28 | 1.36 | 1.05 | 0.80 | 0.70 | 0.76 | 0.74 | 0.71 | 0.63 | 0.50 |
Operating CF/Net income |
(0.09) | (1.33) | 2.57 | 1.84 | 3.54 | 1.60 | 0.90 | 0.68 | (0.78) | 0.43 |
Capex/Depreciation |
(1.11) | (0.31) | (0.91) | (2.75) | (2.72) | (3.75) | (5.47) | (6.93) | (4.03) | (0.68) |
Interest Coverage |
— | — | 39.97 | 12.00 | 28.44 | — | 17.89 | — | — | — |
| (31.61%) | (5.29%) | 5.67% | 9.61% | 3.31% | 12.07% | 13.34% | 5.91% | (5.16%) | (21.70%) | |
| (18.89%) | (3.21%) | 4.22% | 7.50% | 2.54% | 9.12% | 10.38% | 4.70% | (4.05%) | (16.74%) | |
ROIC |
(31.33%) | (9.10%) | 14.21% | 18.39% | 9.44% | 35.18% | 21.96% | 10.63% | (4.72%) | (36.59%) |
Return on Tangible Assets |
(30.14%) | (4.80%) | 3.67% | 8.93% | 2.97% | 10.64% | 12.76% | 5.82% | (5.28%) | (25.43%) |
Average Days of Receivables |
72.37 | 71.92 | 76.40 | 75.33 | 78.67 | 68.94 | 80.15 | 107.21 | 90.58 | 76.32 |
Research and Development Expense of Revenue |
25.07% | 22.12% | 17.77% | 16.84% | 19.53% | 14.69% | 12.65% | 12.55% | 14.44% | 16.73% |
Selling, General and Administrative Expense of Revenue |
61.09% | 52.83% | 50.73% | 49.81% | 48.74% | 48.35% | 50.49% | 57.09% | 65.90% | 78.65% |
Intangible Assets out of Total Assets |
0.03 | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
10.38% | 3.49% | 5.46% | 7.02% | 7.43% | 6.34% | 7.16% | 7.29% | 8.67% | 12.77% |
Graham Net Nets |
0.05 | 0.04 | 0.09 | 0.08 | 0.04 | 0.04 | 0.09 | 0.18 | 0.21 | 0.18 |
Graham Number |
0.00 | 0.00 | 2.70 | 5.01 | 3.37 | 8.51 | 11.23 | 8.97 | 0.00 | 0.00 |
Earnings Yield |
(2.71%) | (0.27%) | 0.33% | 0.88% | 0.15% | 0.64% | 1.56% | 1.51% | (1.69%) | (7.06%) |
Free Cash Flow Yield |
(0.50%) | 0.28% | 0.77% | 1.00% | 0.34% | 0.70% | 0.71% | (0.25%) | (0.65%) | (3.51%) |
Revenue per Share |
2.04 | 2.21 | 2.91 | 3.38 | 3.58 | 4.88 | 5.93 | 6.64 | 6.39 | 4.83 |
Operating CF per Share |
0.03 | 0.07 | 0.30 | 0.58 | 0.46 | 0.93 | 0.74 | 0.30 | 0.32 | (0.69) |
Capex per Share |
(0.08) | (0.03) | (0.05) | (0.23) | (0.18) | (0.29) | (0.38) | (0.37) | (0.48) | (0.12) |
Free Cash Flow per Share |
(0.05) | 0.04 | 0.25 | 0.35 | 0.28 | 0.64 | 0.37 | (0.07) | (0.16) | (0.81) |
Cash per Share |
0.35 | 0.45 | 2.44 | 2.70 | 3.34 | 4.23 | 4.41 | 4.55 | 4.69 | 3.78 |
Shareholders Equity per Share |
0.94 | 1.05 | 3.11 | 3.59 | 4.32 | 5.48 | 7.00 | 7.95 | 8.09 | 6.94 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.94 | 1.05 | 3.11 | 3.59 | 4.32 | 5.48 | 7.00 | 7.95 | 8.09 | 6.94 |
Free Cash Flow |
(2.16) | 1.81 | 10.52 | 15.62 | 12.55 | 30.32 | 17.61 | (3.59) | (7.67) | (40.05) |
Working Capital |
28.45 | 34.80 | 123.84 | 140.19 | 175.18 | 222.61 | 260.01 | 300.23 | 297.63 | 243.04 |
Capital Expenditures |
(3.20) | (1.05) | (2.24) | (10.18) | (8.40) | (13.64) | (18.11) | (18.19) | (23.39) | (5.82) |
Net Current Asset Value |
21.95 | 28.89 | 116.66 | 127.03 | 156.22 | 184.19 | 229.02 | 262.53 | 255.75 | 204.05 |
EV/EBIT |
0.00 | 0.00 | 190.38 | 121.94 | 511.21 | 123.31 | 51.32 | 43.49 | 0.00 | 0.00 |
Capex to Sales |
0.04 | 0.01 | 0.02 | 0.07 | 0.05 | 0.06 | 0.06 | 0.06 | 0.07 | 0.02 |
Price to Operating Income |
0.00 | 0.00 | 206.06 | 132.03 | 533.73 | 129.29 | 56.15 | 51.34 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.25 | 0.34 | 0.22 | 0.22 | 0.13 | 0.10 | 0.07 | 0.04 | 0.07 | 0.12 |
Cash ROIC |
(4.05%) | 2.92% | 4.44% | 5.57% | 3.59% | 6.61% | 3.21% | (0.59%) | (1.22%) | (7.53%) |
Accounts Receivable Turnover |
5.15 | 5.30 | 5.66 | 5.28 | 4.94 | 5.85 | 5.37 | 4.10 | 3.64 | 3.74 |
Accounts Payable Turnover |
3.21 | 3.67 | 5.17 | 5.25 | 5.81 | 6.41 | 6.02 | 5.55 | 4.91 | 4.03 |
Inventory Turnover |
1.57 | 1.87 | 2.16 | 2.26 | 2.56 | 2.93 | 2.94 | 2.35 | 1.90 | 1.15 |
Average Days of Payables |
126.07 | 83.63 | 73.40 | 76.86 | 60.49 | 61.25 | 69.26 | 70.93 | 82.04 | 74.09 |
Days of Inventory on Hand |
224.87 | 184.50 | 187.92 | 163.66 | 146.58 | 121.64 | 144.55 | 183.80 | 212.68 | 355.23 |
Average Receivables |
16.01 | 17.10 | 21.90 | 28.47 | 33.11 | 39.38 | 52.99 | 78.58 | 86.30 | 63.98 |
Average Payables |
7.50 | 7.17 | 6.28 | 7.29 | 7.76 | 8.09 | 10.14 | 12.57 | 15.13 | 14.14 |
Average Inventory |
15.37 | 14.07 | 15.01 | 16.92 | 17.63 | 17.69 | 20.72 | 29.65 | 39.22 | 49.40 |
Average Assets |
64.22 | 66.70 | 117.64 | 187.43 | 232.47 | 301.60 | 382.30 | 453.76 | 499.11 | 480.60 |
Average Common Equity |
38.38 | 40.42 | 87.68 | 146.16 | 178.55 | 227.89 | 297.34 | 361.03 | 391.64 | 370.76 |
Columns are period end dates